Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice

J Neuroimmunol. 2005 Dec;169(1-2):50-8. doi: 10.1016/j.jneuroim.2005.07.017. Epub 2005 Sep 12.

Abstract

Hippocampal insults involving neuroimmune mechanisms can impair learning and memory in a variety of tasks. The present study was designed to assess the effect of pentoxifylline, an inhibitor of tumor necrosis factor alpha (TNFalpha), and insulin-like growth factor-I (IGF-I) on kainate (KA)-induced impairment in spatial memory. Male mice received a subcutaneous injection of a dose of KA (15 mg/kg) that had no cytotoxic effect on hippocampal neurons as confirmed by Fluorojade B staining. This dose resulted in an impairment of spatial memory in a two-trial recognition task 11 days later. Intraperitoneal administration of pentoxifylline (200 mg/kg) abrogated this effect. Repeated intracerebroventricular injection of IGF-I (2 microg/mouse on day 1 followed by 1 microg/mouse on days 2-5) abrogated KA-induced deficits in spatial memory whereas acute IGF-I (2 microg/mouse on day 1 only) had mixed effects. These findings indicate that endogenous TNFalpha is probably involved in the detrimental effects of kainate on cognition and that exogenous IGF-I can oppose these effects, probably by antagonizing TNFalpha-induced neurotoxicity.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Analysis of Variance
  • Animals
  • Behavior, Animal
  • Cognition Disorders / chemically induced
  • Cognition Disorders / drug therapy*
  • Cognition Disorders / pathology
  • Discrimination Learning / drug effects
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Interactions
  • Fluoresceins
  • Free Radical Scavengers / therapeutic use*
  • Hippocampus / cytology
  • Hippocampus / drug effects
  • Insulin-Like Growth Factor Binding Protein 1 / therapeutic use*
  • Kainic Acid*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Motor Activity / drug effects
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / pathology
  • Neurons / drug effects
  • Organic Chemicals / metabolism
  • Pentoxifylline / therapeutic use*

Substances

  • Fluoresceins
  • Free Radical Scavengers
  • Insulin-Like Growth Factor Binding Protein 1
  • Organic Chemicals
  • fluoro jade
  • Pentoxifylline
  • Kainic Acid